NovellusDx
2011
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
M&A
LATEST DEAL TYPE
(Cancelled)
9
INVESTORS
Description
Developer of gene-profiling platform designed to treat cancerous tumors. The company's gene-profiling platform offers a technology that helps in comprehensive, automated, functional gene profiling of cancer tumors of individual patients, enabling oncology professionals to treat every cancer and each patient with the precise treatment and to support pharmaceutical companies with their drugs life cycle.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Diagnostic Equipment
Primary Office
- Jerusalem Bio-Park 5th floor
- Hadassah Medical Center Campus, POB 12057
- Jerusalem 91120
- Israel
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore NovellusDx’s full profile, request a free trial.
NovellusDx Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 17-Dec-2018 | Cancelled | Generating Revenue | |||
| 5. Later Stage VC | 30-Apr-2018 | 000 | 000.00 | Completed | Clinical Trials - Phase 1 | |
| 4. Grant | 31-Jan-2017 | 00000 | 000.00 | Completed | Clinical Trials - Phase 1 | |
| 3. Early Stage VC | 22-Jun-2016 | 000.00 | 000.00 | Completed | Clinical Trials - Phase 1 | |
| 2. Seed Round | 01-Jan-2014 | $1.14M | $5.14M | Completed | Clinical Trials - Phase 1 | |
| 1. Seed Round | 01-Jul-2013 | $4M | $4M | Completed | Clinical Trials - Phase 1 |
NovellusDx Competitors (67)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Foundation Medicine | Corporate Backed or Acquired | Cambridge, MA | 000 | 00000 | 00000000000 | |
| 00000000 000000000 | Venture Capital-Backed | Beijing, China | 000.00 | 00000000000 | 000.00 | |
| 0000 00000000 | Venture Capital-Backed | San Diego, CA | 00 | 00000 | 00000000000 | 00000 |
| 00000000 | Venture Capital-Backed | Austin, TX | 000 | 000.00 | 00000000000 | 000.00 |
| 00000000 000000 | Formerly VC-backed | Redwood City, CA | 000 | 00000 | 00000000 | 00000 |
NovellusDx Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Bio Capital Impact | Other | Minority | 000 0000 | 000000 0 | ||
| Helsinn Investment Fund | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Windham Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| BIRD Foundation | Limited Partner | 000 0000 | 000000 0 | |||
| apica investments group | Other | Minority | 000 0000 | 000000 0 |
NovellusDx Executive Team (8)
1 Former Executive
You’re viewing 5 of 8 executives. Get the full list »NovellusDx Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Asaf Shinar | Pontifax Venture Capital | Board Member | 000 0000 | |
| Charles Woler MD | Self | President of the Board | 000 0000 | |
| Erez Chimovits | OrbiMed | Board Member | 000 0000 | |
| Haim Gil-Ad | NovellusDx | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| Heiner Dreismann | NovellusDx | Board Member | 000 0000 |